Masimo stock surged Wednesday on its upbeat earnings and 2025 outlook, though one analyst cautioned cost reductions could ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025 at 11:35 a.m. Eastern time. A ...

What Happened? Shares of medical tech company Masimo (NASDAQ:MASI) jumped 11.6% in the afternoon session after the company ...

Masimo (NASDAQ:MASI – Get Free Report) had its price objective upped by equities researchers at Piper Sandler from $210.00 to $215.00 in a report released on Wednesday,Benzinga reports. The brokerage ...

Masimo impressed with a robust earnings report driven by its healthcare segment, despite challenges from non-healthcare ...

Masimo says strategic realignment efforts near the end of last year increased the digital health pioneer's earnings power.

Wells Fargo raised the firm’s price target on Masimo (MASI) to $205 from $193 and keeps an Overweight rating on the shares. The firm is ...

Masimo Corporation’s MASI share price has surged by 12.35%, which has investors questioning if this is right time to sell.

Piper Sandler analyst Jason Bednar raised the firm’s price target on Masimo (MASI) to $215 from $210 and keeps an Overweight rating on the ...

Masimo Corp (MASI) reports robust financial performance with a 9% revenue increase, while navigating strategic realignment ...

In its fourth-quarter earnings report, the medical technology maker guided for adjusted earnings per share of $5.10 to $5.40 in 2025, ahead of the $4.69 a share analysts polled by FactSet were ...

Medtech companies have their eye on the growing hospital-at-home market, which is driven largely by the rising elderly ...